Article
Targeting alternative splicing in cancer immunotherapy
10 Aug 2023
Abstract excerpt
Tumor immunotherapy has made great progress in cancer treatment but still faces several challenges, such as a limited number of targetable antigens and varying responses among patients. Alternative splicing (AS) is an essential process for the maturation of nearly all mammalian mRNAs. Recent studies show that AS contributes to expanding cancer-specific antigens and modulating immunogenicity, making it a promising...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
